Citations

Mayo Clinic

Showing 10 of 108551 citations.

Ultrasound-Based Noncontrast Microvascular Imaging for Evaluation of Breast Lesions: Imaging Techniques and Review of Diagnostic Criteria
Mohindra, Namita , Soni, Neetu

Indian Journal of Radiology and Imaging | March 17, 2024 | Volume: 34 | Issue: 04 | Pages: 702-713

10.1055/s-0044-1782162 | PMID 39318571 Get It

AbstractVascularity plays a pivotal role in the progression of breast lesions and may be associated with their aggressiveness and likelihood of being malignant. Contrast-enhanced imaging techniques are necessary to evaluate vascularity due to the limited sensitivity of conventional color Doppler techniques, in which motion artifacts are eliminated using wall filters. However, in this process, low-flow signals from small vessels also get removed unintentionally. Advancements in technology have revolutionized the way ultrasound images are generated, resulting in tremendous improvements in Doppler imaging techniques. The new, ultrasound-based noncontrast microvascular imaging techniques overcome the limitations of conventional Doppler, and are highly sensitive for detecting microvessels and low flow. The resultant high Doppler sensitivity leads to detection of vascularity in more breast lesions. It is important for radiologists to understand the imaging principles and the clinical implications of the new techniques, to optimally utilize them and aid correct diagnosis. Angio-PLUS is one such recent advancement, which uses unfocused or plane waves and three-dimensional wall filtering to analyze tissue motion in time, space, and amplitude domains that effectively distinguish between blood flow and tissue. The information is beneficial for assessing the lesion vascularity without using contrast. This article aims to explain the Doppler imaging techniques, their clinical applications, scanning methods, and review the common Doppler-based diagnostic criteria used in the evaluation of breast lesions.
Testing for SARS-CoV-2: lessons learned and current use cases
Theel, Elitza S. , Kirby, James E. , Pollock, Nira R.

Clinical Microbiology Reviews | March 17, 2024 | Volume: 37 | Issue: 2 | Pages: No page available

10.1128/cmr.00072-23 | PMID 38488364 Get It

SUMMARY The emergence and worldwide dissemination of SARS-CoV-2 required both urgent development of new diagnostic tests and expansion of diagnostic testing capacity on an unprecedented scale. The rapid evolution of technologies that allowed testing to move out of traditional laboratories and into point-of-care testing centers and the home transformed the diagnostic landscape. Four years later, with the end of the formal public health emergency but continued global circulation of the virus, it is important to take a fresh look at available SARS-CoV-2 testing technologies and consider how they should be used going forward. This review considers current use case scenarios for SARS-CoV-2 antigen, nucleic acid amplification, and immunologic tests, incorporating the latest evidence for analytical/clinical performance characteristics and advantages/limitations for each test type to inform current debates about how tests should or should not be used.
Identification of the novel HLA‐DQA1*05:101 allele by next‐generation sequencing in a family
Du, Zeying , Murrin, Michelle E., Patel, Pritesh B., Williams, C. D. H., Elrefaei, Mohamed , Williams, Charles D, Du, Zeying , Williams, Charles D.

HLA | March 16, 2024 | Volume: 103 | Issue: 3 | Pages: No page available

10.1111/tan.15443 | PMID 38488750 Get It

HLA‐DQA1*05:101 differs from HLA‐DQA1*05:01:01:02 by one nucleotide substitution at codon 221 (CGT>TGT) in exon 4.
Managing blood product shortages: Unprecedented challenges require novel solutions
Jacobs, Jeremy W. , Raza, Sheharyar , Woo, Jennifer S. , Woo, Jennifer S , Jacobs, Jeremy W

Transfusion | March 16, 2024 | Volume: 64 | Issue: 3 | Pages: 565-566

10.1111/trf.17723 | PMID 38488299 Get It

Clinical validation of the VIPUN™ gastric monitoring system versus manometry for the evaluation of gastric motility
Raymenants, Karlien , Huang, I‐Hsuan , Tichelen, Nico Van, Burton, Duane D. , Tack, Jan , Burton, Duane, Tack, Jan , Goelen, Nick , Janssen, Pieter

Neurogastroenterology & Motility | March 16, 2024 | Volume: 36 | Issue: 6 | Pages: No page available

10.1111/nmo.14783 | PMID 38488253 Get It

AbstractBackgroundGastrointestinal dysmotility is frequently suspected in patients with gastroparesis, functional dyspepsia, and ileus, and in the intensive care unit. Monitoring of gastric motility in clinical practice remains challenging. A novel technology was developed to meet the medical need for a widely available bedside tool to monitor gastric motility continuously. The VIPUN™ Gastric Monitoring System (GMS) comprises a nasogastric feeding tube with intragastric balloon to allow for measuring gastric contractions.AimsTo compare the performance of the VIPUN GMS versus a reference technique (manometry).MethodsIn this validation study in healthy subjects, the investigational catheter and a solid‐state manometry catheter were placed in the stomach concomitantly. Motility was recorded for 2.5 h: 2 h in a fasting state, followed by a 400‐kcal liquid meal, and monitoring of the fed state for the remaining half hour. The performance of both systems was compared by automated recognition and manual identification of the contractile activity. Data are presented as mean (standard deviation).Key ResultsThe analysis set comprised 13 healthy subjects (6 women, age: 27.5 (8.1) years, BMI: 22.2 (2.46) kg/m2). Automatically‐recognized contractility was strongly correlated between the two techniques (endpoint: contraction duration; Spearman ρ = 0.96, p < 0.001). A correlation was also observed between the number of individual contractions identified by expert gastroenterologists on both technologies independently (ρ = 0.71, p = .007) and between the contractions identified by the experts and by the GMS software (ρ = 0.87, p = 0.001). No serious or unanticipated adverse events occurred.Conclusions & InferencesThe observed strong correlations with the gold standard, manometry, validate the performance of the VIPUN GMS as a gastric monitoring system.
Long‐term outcomes with abandoning versus extracting sterile leads: A 10‐year population‐based study
Lee, Justin Z. , Talaei, Fahimeh , Sorajja, Dan , Valverde, Arturo M. , Scott, Luis R. , Asirvatham, Samuel J. , Kusumoto, Fred , Mulpuru, Siva K. , Cha, Yong‐Mei , Tan, Min Choon , Valverde, Arturo, Asirvatham, Samuel J , Kusumoto, Fred M , Cha, Yong-Mei , Srivathsan, Komandoor

Pacing and Clinical Electrophysiology | March 16, 2024 | Volume: 47 | Issue: 5 | Pages: 626-634

10.1111/pace.14940 | PMID 38488756 Get It

Abstract Background Long‐term outcomes of sterile lead management strategies of lead abandonment (LA) or transvenous lead extraction (TLE) remain unclear. Methods We performed a retrospective study of a population residing in southeastern Minnesota with follow‐up at the Mayo Clinic and its health systems. Patients who underwent LA or TLE of sterile leads from January 1, 2000, to January 1, 2011, and had follow‐up for at least 10 years or until their death were included. Results A total of 172 patients were included in the study with 153 patients who underwent LA and 19 who underwent TLE for sterile leads. Indications for subsequent lead extraction arose in 9.1% ( n = 14) of patients with initial LA and 5.3% ( n = 1) in patients with initial TLE, after an average of 7 years. Moreover, 28.6% of patients in the LA cohort who required subsequent extraction did not proceed with the extraction, and among those who proceeded, 60% had clinical success and 40% had a clinical failure. Subsequent device upgrades or revisions were performed in 18.3% of patients in the LA group and 31.6% in the TLE group, with no significant differences in procedural challenges (5.2% vs. 5.3%). There was no difference in 10‐year survival probability among the LA group and the TLE group ( p = .64). Conclusion An initial lead abandonment strategy was associated with more complicated subsequent extraction procedures compared to patients with an initial transvenous lead extraction strategy. However, there was no difference in 10‐year survival probability between both lead management approaches.
Clinical evaluation of a stereotactic system for single-stage deep brain stimulation surgery under general anesthesia: technical note
Scheitler, Kristen M. , Rusheen, Aaron E. , Goyal, Abhinav , Hong, Sukwoo , Osman, Gamaleldin , Sharaf, Basel , Klassen, Bryan T. , Miller, Kai J. , Shin, Hojin , Lee, Kendall H. , Sharaf, Basel A , Yuen, Jason , Grewal, Sanjeet S. , Oh, Yoonbae

Journal of Neurosurgery | March 16, 2024 | Volume: 141 | Issue: 2 | Pages: 406-411

10.3171/2024.1.jns232563 | PMID 38489816 Get It

OBJECTIVE Conventional frame-based stereotactic systems have circumferential base frames, often necessitating deep brain stimulation (DBS) surgery in two stages: intracranial electrode insertion followed by surgical re-preparation and pulse generator implantation. Some patients do not tolerate awake surgery, underscoring the need for a safe alternative for asleep DBS surgery. A frame-based stereotactic system with a skull-mounted "key" in lieu of a circumferential base frame received US FDA clearance. The authors describe the system’s application for single-stage, asleep DBS surgery in 8 patients at their institution and review its workflow and technical considerations. METHODS Eight patients underwent DBS lead insertion and IPG implantation in a single surgical preparation under general anesthesia using the system. Postoperative CT imaging confirmed lead placement. RESULTS Eight patients underwent implantation of 15 total leads targeting the ventral intermediate nucleus (4 patients), globus pallidus internus (GPi; 3 patients), and subthalamic nucleus (STN; 1 patient). Intraoperative microelectrode recording was conducted for GPi and STN targets. Postoperative CT imaging revealed a mean ± SD radial error of 1.24 ± 0.45 mm (n = 15 leads), without surgical complications. CONCLUSIONS The stereotactic system facilitated safe and effective asleep, single-stage DBS surgery, maintaining traditional lead accuracy standards.
Impacts of environmental tobacco smoke on the onset and progression of multiple sclerosis: a systematic review
Schlindwein, Marco Antônio Machado , Campos, Marcelo Henrique De Moura , Breis, Letícia Caroline , Chara, Beatriz Sordi , Scherer, Clara Sasse , Caminski, Vitória Augusta Piva , Matta, André Palma da Cunha , Gonçalves, Marcus Vinícius Magno , de Moura Campos, Marcelo Henrique , Matta, André , Sordi Chara, Beatriz

Arquivos de Neuro-Psiquiatria | March 16, 2024 | Volume: 82 | Issue: 03 | Pages: 1-10

10.1055/s-0044-1779271 | PMID 38490261 Get It

Abstract Background Unlike cigarette smoking, environmental tobacco smoke (ETS) has not been as well described as an environmental risk for Multiple sclerosis (MS) nor as a risk factor for disease progression. Objective We systematically reviewed the association between ETS and the risk of onset and/or progression of MS. Methods We systematically screened MedLine/PubMed, Science Direct, LILACs, and SciELO searching for publications between January 1st, 2010, and July 5, 2021, with the following keywords: “multiple sclerosis and smoking”; “multiple sclerosis and passive smoking”; “multiple sclerosis and secondhand smoking”. Results Fifteen articles were included in this review, which consisted of systematic reviews with meta-analysis (N = 2), systematic reviews (N = 2), and observational studies (N = 11). Both meta-analyses reported an impact of ETS on MS onset among secondhand smokers. One of the systematic reviews selected two observational studies showing the association between ETS and MS development, and one study that did not find a significant association between ETS and the risk of MS development. The other systematic review identified selected eight articles showing a relationship between ETS and MS. Seven observational studies reported higher odds of MS onset when associated with ETS. Four observational studies did not show a relationship between ETS and MS onset or progression. Conclusion Most articles showed a positive association between ETS exposure and the risk of developing MS. On the other hand, an association between ETS and a higher risk for MS progression could not be established.
Choroid plexus calcifications are not associated with putative markers of glymphatic dysfunction: A population study in middle-aged and older adults
Castillo, Pablo R. , Patel, Vishal , Brutto, Óscar H. Del , Del Brutto, Oscar H , Castillo, Pablo R , Mera, Robertino M. , Rumbea, Denisse A.

The Neuroradiology Journal | March 15, 2024 | Volume: 37 | Issue: 3 | Pages: 342-350

10.1177/19714009241240315 | PMID 38490679 Get It

Background and Purpose Recent studies have suggested an association between dysfunction of the choroid plexus and the glymphatic system. However, information is inconclusive. Following a population-based study design, we aimed to assess the association between choroid plexus calcifications (CPCs)—as a surrogate of choroid plexus dysfunction—and severity and progression of putative markers of glymphatic dysfunction, including white matter hyperintensities (WMH) of presumed vascular origin and abnormally enlarged basal ganglia perivascular spaces (BG-PVS). Methods This study recruited community-dwellers aged ≥40 years living in neighboring Ecuadorian villages. Participants who had baseline head CTs and brain MRIs were included in cross-sectional analyses and those who additional had follow-up MRIs (after a mean of 6.4 ± 1.5 years) were included in longitudinal analyses. Logistic and Poisson regression models, adjusted for demographics and cardiovascular risk factors, were fitted to assess associations between CPCs and WMH and enlarged BG-PVS severity and progression. Results A total of 590 individuals were included in the cross-sectional component of the study, and 215 in the longitudinal component. At baseline, 25% of participants had moderate-to-severe WMH and 27% had abnormally enlarged BG-PVS. At follow-up, 36% and 20% of participants had WMH and enlarged BG-PVS progression, respectively. Logistic regression models showed no significant differences between CPCs volumes stratified in quartiles and severity of WMH and enlarged BG-PVS. Poisson regression models showed no association between the exposure and WMH and enlarged BG-PVS progression. Baseline age remained significant in these models. Conclusions Choroid plexus calcifications are not associated with putative markers of glymphatic system dysfunction.
Imaging-based noninvasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline
Duarte‐Rojo, Andrés , Taouli, Bachir , Leung, Daniel H. , Levine, Deborah , Nayfeh, Tarek , Alsawaf, Yahya , Saadi, Samer , Majzoub, Abdul M., Haffar, Samir , Dundar, Ayca , Sterling, Richard K. , Hasan, Bashar , Alsawaf, Yahya , Majzoub, Abdul Mounaem, Murad, M Hassan , Rockey, Don C , Alsawas, Mouaz , Sterling, Richard K , Duarte-Rojo, Andres , Nayfeh, Tarek , Levine, Deborah , Taouli, Bachir , Saadi, Samer , Hasan, Bashar , Manolopoulos, Apostolos , Murad, M. Hassan , Rockey, Don C. , Alsawas, Mouaz

Hepatology | March 15, 2024 | Volume: 81 | Issue: 2 | Pages: 725-748

10.1097/hep.0000000000000852 | PMID 38489521 Get It

Background and Aims: Transient elastography (TE), shear wave elastography, and/or magnetic resonance elastography (MRE), each providing liver stiffness measurement (LSM), are the most studied imaging-based noninvasive liver disease assessment (NILDA) techniques. To support the American Association for the Study of Liver Diseases guidelines on NILDA, we summarized the evidence on the accuracy of these LSM methods to stage liver fibrosis (F). Approach and Results: A comprehensive search for studies assessing LSM by TE, shear wave elastography, or MRE for the identification of significant fibrosis (F2-4), advanced fibrosis (F3-4), or cirrhosis (F4), using histopathology as the standard of reference by liver disease etiology in adults or children from inception to April 2022 was performed. We excluded studies with <50 patients with a single disease entity and mixed liver disease etiologies (with the exception of HCV/HIV coinfection). Out of 9447 studies, 240 with 61,193 patients were included in this systematic review. In adults, sensitivities for the identification of F2-4 ranged from 51% to 95%, for F3-4 from 70% to 100%, and for F4 from 60% to 100% across all techniques/diseases, whereas specificities ranged from 36% to 100%, 74% to 100%, and 67% to 99%, respectively. The largest body of evidence available was for TE; MRE appeared to be the most accurate method. Imaging-based NILDA outperformed blood-based NILDA in most comparisons, particularly for the identification of F3-4/F4. In the pediatric population, imaging-based NILDA is likely as accurate as in adults. Conclusions: LSM from TE, shear wave elastography, and MRE shows acceptable to outstanding accuracy for the detection of liver fibrosis across various liver disease etiologies. Accuracy increased from F2-4 to F3-4 and was the highest for F4. Further research is needed to better standardize the use of imaging-based NILDA, particularly in pediatric liver diseases.